doi: 10.3390/ijms22105161
Receptor overlap
Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug Interactions), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
Since research on IGF-1 LR3 has not progressed beyond preclinical studies, we do not know how it will behave in the human body, and it is not approved for human use outside of research settings
For competitive athletes there is a separate, definitive problem: WADA classifies BPC-157 as an S0 prohibited substance, meaning any in-competition or out-of-competition use is sanctionable [13]
